Development of a nongenetic mouse model of type 2 diabetes

Experimental Diabetes Research

Volumn 2011, Issue , 2011, Pages

  Gilbert, Elizabeth R ^a   Fu, Zhuo ^a   Liu, Dongmin ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; STREPTOZOCIN; HIGH DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CALORIC INTAKE; COMPARATIVE STUDY; DISEASE MODEL; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INTRAABDOMINAL FAT; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; TIME;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY INTAKE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; ISLETS OF LANGERHANS; LIPOPROTEINS, HDL; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; RANDOM ALLOCATION; STREPTOZOCIN; TIME FACTORS;

EID: 84862956027     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2011/416254     Document Type: Article

References (31)

1. ADA Total prevalence of diabetes and pre-diabetes, 2009
2. King H., Aubert R. E., Herman W. H., Global burden of diabetes, 19952025: prevalence, numerical estimates, and projections Diabetes Care 1998 21 9 1414 1431 (Pubitemid 28405191)
3. Clee S. M., Attie A. D., The genetic landscape of type 2 diabetes in mice Endocrine Reviews 2007 28 1 48 83 (Pubitemid 46220850)
4. Reuter T. Y., Diet-induced models for obesity and type 2 diabetes Drug Discovery Today: Disease Models 2007 4 1 3 8 (Pubitemid 350286528)
5. Leiter E. H., Selecting the right mouse model for metabolic syndrome and type 2 diabetes research Methods in Molecular Biology 2009 560 1 17
6. Luo J., Quan J., Tsai J., Hobensack C. K., Sullivan C., Hector R., Reaven G. M., Nongenetic mouse models of non-insulin-dependent diabetes mellitus Metabolism 1998 47 6 663 668 (Pubitemid 28265168)
7. Kahn B. B., Flier J. S., Obesity and insulin resistance The Journal of Clinical Investigation 2000 106 4 473 481 (Pubitemid 30666380)
8. Srinivasan K., Viswanad B., Asrat L., Kaul C. L., Ramarao P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharmacological Research 2005 52 4 313 320 (Pubitemid 41175991)
9. Islam M. S., Choi H., Nongenetic model of type 2 diabetes: a comparative study Pharmacology 2007 79 4 243 249 (Pubitemid 46848544)
10. Fu Z., Zhang W., Zhen W., Lum H., Nadler J., Bassaganya-Riera J., Jia Z., Wang Y., Misra H., Liu D., Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice Endocrinology 2010 151 7 3026 3037
11. Weibel E. R., The value of stereology in analysing structure and function of cells and organs Journal of Microscopy 1972 95 1 3 13
12. Kirk R. E., Experimental Design: Procedures for the Behavioral Sciences 1982
13. Stoffers D. A., The development of β-cell mass: recent progress and potential role of GLP-1 Hormone and Metabolic Research 2004 36 11-12 811 821 (Pubitemid 40115904)
14. Tourrel C., Bailbe D., Lacorne M., Meile M. J., Kergoat M., Portha B., Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the β-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4 Diabetes 2002 51 5 1443 1452 (Pubitemid 34826610)
15. Sakuraba H., Mizukami H., Yagihashi N., Wada R., Hanyu C., Yagihashi S., Reduced β-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients Diabetologia 2002 45 1 85 96 (Pubitemid 34118546)
16. Marchetti P., Del Guerra S., Marselli L., Lupi R., Masini M., Pollera M., Bugliani M., Boggi U., Vistoli F., Mosca F., Del Prato S., Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin Journal of Clinical Endocrinology and Metabolism 2004 89 11 5535 5541 (Pubitemid 39518437)
17. Cozar-Castellano I., Fiaschi-Taesch N., Bigatel T. A., Takane K. K., Garcia-Ocaa A., Vasavada R., Stewart A. F., Molecular control of cell cycle progression in the pancreatic β-cell Endocrine Reviews 2006 27 4 356 370 (Pubitemid 43848303)
18. Sreenan S., Pick A. J., Levisetti M., Baldwin A. C., Pugh W., Polonsky K. S., Increased β-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse Diabetes 1999 48 5 989 996 (Pubitemid 29226344)
19. Suarez-Pinzon W. L., Yan Y., Power R., Brand S. J., Rabinovitch A., Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycemia in diabetic NOD mice Diabetes 2005 54 9 2596 2601 (Pubitemid 41233580)
20. Wang Q., Brubaker P., Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice Diabetologia 2002 45 9 1263 1273
21. Rolin B., Larsen M. O., Gotfredsen C. F., The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice American Journal of Physiology 2002 283 E745 E752
22. Rankin M. M., Kushner J. A., Adaptive β-cell proliferation is severely restricted with advanced age Diabetes 2009 58 6 1365 1372
23. Tschen S. I., Dhawan S., Gurlo T., Bhushan A., Age-dependent decline in β-cell proliferation restricts the capacity of β-cell regeneration in mice Diabetes 2009 58 6 1312 1320
24. Strowski M. Z., Li Z., Szalkowski D., Shen X., Guan X. M., Jttner S., Moller D. E., Zhang B. B., Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes Endocrinology 2004 145 11 5259 5268 (Pubitemid 39551148)
25. Mu J., Woods J., Zhou Y. P., Roy R. S., Li Z., Zycband E., Feng Y., Zhu L., Li C., Howard A. D., Moller D. E., Thornberry N. A., Zhang B. B., Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes Diabetes 2006 55 6 1695 1704 (Pubitemid 44324122)
26. Goldberg I. J., Clinical review 124: diabetic dyslipidemiacauses and consequences Journal of Clinical Endocrinology and Metabolism 2001 86 3 965 971 (Pubitemid 32322966)
27. Mathe D., Dyslipidemia and diabetes: animal models Diabete et Metabolisme 1995 21 2 106 111
28. Schnedl W. J., Ferber S., Johnson J. H., Newgard C. B., STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells Diabetes 1994 43 11 1326 1333
29. Matveyenko A. V., Butler P. C., β-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes Diabetes 2006 55 7 2106 2114 (Pubitemid 44509986)
30. Wajchenberg B. L., β-cell failure in diabetes and preservation by clinical treatment Endocrine Reviews 2007 28 2 187 218 (Pubitemid 46984834)
31. Donath M. Y., Ehses J. A., Maedler K., Schumann D. M., Ellingsgaard H., Eppler E., Reinecke M., Mechanisms of β-cell death in type 2 diabetes Diabetes 2005 54 2 S108 S113